Glad to be given the opportunity to share on types of bifurcation stenting, mainly focusing on provisional stenting, DK crush & Culotte stenting today at IJN, organized by Medtronic.
Thanks to Datuk Dr Shaiful, Datuk Dr Kumara, Dato Sri Dr Azhari Rosman & Dato Dr Amin!
Good to play on the model and test out some issues/rewiring issues as well. I still remember my 1st DK Crush was done with Dr Lee Tjen Jhung!
Managed to let the fellows to do a few techniques with the models
Forxiga (dapagliflozin) has emerged as a game-changer in managing chronic kidney disease (CKD). Traditionally used as a treatment for Type 2 diabetes, Forxiga is now recognized for its kidney-protective benefits, offering hope to millions of CKD patients worldwide. Glad to be able to share with group of doctors from LifeCare Diagnostic, led by Dr Ong!
How Forxiga Works in CKD Forxiga belongs to a class of medications known as SGLT2 inhibitors, which work by helping the kidneys remove excess glucose through urine. Beyond its glucose-lowering effects, Forxiga has been shown to reduce the progression of kidney disease by improving kidney function, lowering protein in the urine, and reducing the risk of kidney failure.
Forxiga’s Clinical Benefits in CKD Recent studies have demonstrated Forxiga’s ability to significantly delay CKD progression. This means fewer patients advancing to end-stage renal disease (ESRD) and reduced dependence on dialysis or kidney transplants. It has also been shown to lower cardiovascular risks, which is a common complication for CKD patients.
Who Can Benefit from Forxiga? Forxiga is not just for diabetic patients. Recent guidelines recommend its use in CKD patients with or without diabetes, making it an essential treatment option for a broader patient population.
Conclusion Forxiga offers a promising solution for those suffering from chronic kidney disease. With its ability to slow disease progression and improve overall kidney health, Forxiga is a vital part of modern CKD treatment strategies.
The SEQuent Please NEO Drug-Coated Balloon (DCB) is revolutionizing vascular intervention, and I recently had the chance to dive deep into its potential at a dedicated workshop. Thanks to Dato Sri Dr Azhari Rosman, Dato Dr Amin, Datuk Dr Shaiful, Datuk Dr Kumara & BBraun team!
This cutting-edge device, designed for precise drug delivery without the need for a stent, offers a promising solution for treating coronary artery disease.
The workshop covered the unique features of the SEQuent Please NEO DCB, including its ultra-thin balloon coating and innovative drug delivery system, which ensure optimal healing and minimal vessel damage. We also reviewed clinical cases, showing how the device effectively treats in-stent restenosis and other complex lesions.
What impressed me most was the emphasis on patient outcomes and the growing body of evidence supporting the SEQuent Please NEO’s efficacy and safety. It was a great opportunity to learn from industry experts and gain hands-on experience with this advanced technology.
Thanks once again to the organizer for the invitation, I have learnt alot as well from this workshop!
Recently I had the opportunity to attend the AGENTDCB Workshop, and it was an eye-opener. The session was packed with valuable insights on the latest advancements in drug-coated balloon technology, specifically the AGENT DCB, which is designed to optimize vascular intervention outcomes.
The workshop featured updates on clinical data, case studies and interactive discussions led by leading interventional cardiologists. It was fascinating to see how the AGENT DCB offers superior drug delivery and vessel healing, addressing the limitations of traditional balloon angioplasty. We explored its clinical applications, benefits, and recent trial data that highlight its effectiveness in treating complex lesions.
Overall, the workshop was an excellent opportunity to learn, network, and stay updated on cutting-edge innovations in vascular care. If you get the chance to attend a similar event, I highly recommend it!
Empagliflozin is an SGLT-2 inhibitor originally used for managing type 2 diabetes. Recent studies have shown its efficacy in treating chronic kidney disease (CKD), regardless of diabetic status. By reducing blood glucose levels, empagliflozin also helps to lower blood pressure, reduce proteinuria, and mitigate the progression of kidney damage.
Great Q&A sessions about SGLT2i and as well as general cardiology questions.
The EMPA-KIDNEY trial demonstrated significant benefits, showing that empagliflozin slows down CKD progression, reduces cardiovascular risk, and lowers the likelihood of hospitalization due to heart failure. Its kidney-protective effects are believed to stem from reducing intraglomerular pressure, improving metabolic parameters, and decreasing inflammation and fibrosis in the kidneys.
I have learnt alot from Dato Sri as well as the GPs!
Overall, empagliflozin represents a promising treatment option for CKD patients, with or without diabetes, offering improved renal and cardiovascular outcomes.
Grateful for the opportunity given and hope to have more in future!
Had a golden opportunity to visit Tokyo, Japan for a 2 days observership program at Okamura Memorial Hospital! Thanks to Datuk Dr Shaiful, Dato Sri Dr Azahri Rosman, Datuk Dr Kumara, Dr Hafidz from IJN!
This is my 1st time visiting Japan! Took bullet train to Shimizu, checked in to Fujisan Mishima Tokyu Hotel with great view of Mount Fuji from my room!
We were greeted by Sensei Dr Hosaka, Consultant Interventional Cardiologist and one of the very famous CTO operator in Japan!
Managed to observe 5 cases on Day 1 till 10pm at night and 2 cases on Day 2!
Good mixture of complex cases such as CTO, calcified lesion needed Rotablation, OAS, DCA, imaging with latest OCT Ultreon 2.0 by Abbott and Terumo IVUS, not to forget Impella CP with smart assist. They inserted Impella just like their daily routine!
Fruitful visit despite only 2 days short trip. They Rota at speed of 220-230k RPM!
Come out already dark sky, dinner became supper hehehe
They prepared our scrub with white coat nicely on table, really the Japan way of doing things!
Had OCT lecture from Sensei Dr Masahiko Ochiai.
Dr Shinji Imura, Sensei Dr Hosaka, Sensei Dr Ando Elements, Dr Yuki Nakanishi!
Managed to had a quick walk around Tokyo before flying back to KL the next day morning.
The Tokyo skylines are similar to New York!
The Tokyo Imperial Palace
The famous Shibuya crossing where Tokyo Drift filmed their movie
The famous Hachiko, the faithful dog!
Tokyo Tower
Not to forget the nice Japanese food!
Thanks Abbott for the hospitality, great learning, great introduction to OCT Ultreon 2.0 & great place!
